Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Preferred Dividend Payments (2023 - 2025)

Benitec Biopharma has reported Preferred Dividend Payments over the past 2 years, most recently at $619.0 million for Q1 2025.

  • Quarterly results put Preferred Dividend Payments at $619.0 million for Q1 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $619.0 million (up 99897.9% YoY), and the annual figure for FY2024 was $619000.0, changed.
  • Preferred Dividend Payments reached $619.0 million in Q1 2025 per BNTC's latest filing, up from $619000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $619.0 million in Q1 2025 and bottomed at $619000.0 in Q3 2023.